Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublinesTony T. Wu, Leland W.K. Chung, Robert A. Sikes et al.|International Journal of Cancer|1998Cited by 291
A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.Shigeji Matsubara, Leland W.K. Chung, Yoshitaka Wada et al.|PubMed|2001Cited by 149
Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate CancerHiroyuki Kubo, Leland W.K. Chung, Thomas A. Gardner et al.|Human Gene Therapy|2003Cited by 127
Molecular Therapy with Recombinant p53 Adenovirus in an Androgen-Independent, Metastatic Human Prostate Cancer ModelSong-Chu Ko, Leland W.K. Chung, Akinobu Gotoh et al.|Human Gene Therapy|1996Cited by 125
Osteocalcin-directed gene therapy for prostate-cancer bone metastasisKenneth S. Koeneman, Thomas A. Gardner, Chinghai Kao et al.|World Journal of Urology|2000Cited by 121